Company profile: Biopta
1.1 - Company Overview
Company description
- Provider of human tissue-based contract research services for drug development, using ethically donated fresh human tissues from surgery to predict drug behavior and bridge animal studies and clinical trials. Services include fresh human tissue pharmacology, a digital human tissue assay catalog, Alvetex 3D tissue models, REPROSKIN full-thickness skin, neurite outgrowth models, and clinical lab services with AI-driven biospecimen analysis.
Products and services
- Human Tissue Pharmacology: Biopta employs fresh human tissues to predict drug behavior and bridge animal-to-clinic translation, delivering research-grade ex vivo test systems for evaluating new pharmaceutical compounds
- Alvetex Bioengineered 3D Tissue Services: Services using Alvetex technology to create 3D tissue models that replicate human biology for drug testing, supplying custom-engineered in vitro human tissue models
- Clinical Laboratory Services: Specialized laboratory services for processing and analyzing human biospecimens with AI-driven data analysis, delivering AI-driven assessment of human tissue samples
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biopta
Reverba
HQ: United States
Website
- Description: Provider of patient engagement solutions for pharmaceutical and biotechnology companies, including clinical patient engagement programs powered by the reverbaBRIDGE platform, global clinical trial optimization with patient-centered approaches and real-time data insights, expert recruitment, tech-enabled relationship management and automation, and total compliance with HIPAA, GDPR, and FDA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reverba company profile →
Aptus Clinical
HQ: United Kingdom
Website
- Description: Provider of specialist clinical contract research services, offering Catalyst Oncology, a clinical research organization focusing on oncology supporting biotech companies in developing cancer therapies, and Catalyst Flex, multi-therapeutic functional service provider solutions including clinical operations, data management, biostatistics, programming, safety, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptus Clinical company profile →
Biofer
HQ: Italy
Website
- Description: Provider of organic and inorganic medicinal chemicals and active pharmaceutical ingredients, including iron complexes for anemia, heparins and glycosaminoglycans as antithrombotics to prevent blood clots, steroids for anti-shock and antiallergic uses, folinates as antitumor adjuvants supporting cancer therapies, and enzymes as anti-inflammatories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biofer company profile →
Qualicaps
HQ: United States
Website
- Description: Provider of two-piece empty pharmaceutical capsules and processing equipment, including gelatin capsules for oral dosage forms and dry powder inhalers; plant-based hypromellose capsules suited to moisture-sensitive APIs; inhalation capsules with superior aerosolization; and capsule filling, band-sealing, and visual inspection machines for precision, integrity, and quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qualicaps company profile →
Pfanstiehl
HQ: United States
Website
- Description: Provider of cGMP-produced high-purity, injectable-grade excipients and bioprocessing solutions, specializing in isolation, purification, custom synthesis, and scale-up of regulated, low endotoxin injectable formulation ingredients, pharmaceutical intermediates, and APIs in gram to multi-ton quantities. Products include TRIS HCl, sodium gluconate, sucrose, trehalose, galactose, and L-arginine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pfanstiehl company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biopta
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biopta
2.2 - Growth funds investing in similar companies to Biopta
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biopta
4.2 - Public trading comparable groups for Biopta
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →